Phase 3 Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 80 years of age (inclusive).
- People with a performance status score of 0–2, which is a doctor's rating of how much a person's daily activities are affected by their illness (confirm with trial site).
- People who have been diagnosed with primary epithelial ovarian cancer (confirmed through laboratory testing of tissue or cell samples), at an advanced stage (FIGO stage III or IV) after surgery, and who are scheduled to receive standard post-surgery platinum-based chemotherapy.
- People who have already had ovarian cancer debulking surgery, are in a stable condition at the time of joining the trial (meaning no active infection or serious liver or kidney problems), and are planned to receive post-surgery chemotherapy.
- People who meet the criteria for ovarian cancer-related insomnia, defined as trouble falling asleep, waking up during the night two or more times, or waking up very early and being unable to go back to sleep — happening at least three nights per week for at least one month.
- People who are able to understand assessment questionnaires and participate in a structured talking therapy for insomnia, such as those with a cognitive screening score of 24 or above, or who have completed at least primary school education.
- People who voluntarily agree to participate, consent to the study treatment in writing, and are able to fill in a sleep diary on their own.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously received a full course of Cognitive Behavioral Therapy for Insomnia.
- People who had chronic insomnia, depression, or other mental health conditions before their ovarian cancer diagnosis, AND who score 15 or above on both a depression questionnaire (PHQ-9) and an anxiety questionnaire (GAD-7), AND who have been using sleeping pills or psychiatric medications long-term.
- People who are pregnant or breastfeeding.
- People who have serious existing conditions affecting the heart, brain and blood vessels, lungs, liver, kidneys, or blood-forming system.
- People who have language difficulties that would prevent them from completing assessments or taking part in therapy.
- People who have autoimmune diseases, immune deficiency conditions (present from birth or developed over time), blood disorders, or who have been taking corticosteroids or immunosuppressant medications long-term.
- People with active hepatitis B, active tuberculosis, or other serious or uncontrolled infectious diseases.
- People with a history of long-term alcohol dependence.
- People who currently have another primary cancer diagnosis (with some exceptions, such as certain types of previously cured skin cancer or cervical carcinoma in situ — confirm with trial site).
- People who have taken part in another clinical trial within the three months before joining this trial.
- People who are not legally able to consent on their own behalf, or where there is a medical or ethical reason that could prevent them from continuing in the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jianhui Tian, Shanghai Hospital of Traditional Chinese Medicine
Phone: 86+18917763382
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PSQI Response Rate; Progression-Free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.